Zdrowie i gospodarka · 23/07/2019

FDA Releases Final Guidance on Postmarketing Safety Reporting for Combination Products

The Food and Drug Administration (FDA) has made available a final guidance document outlining postmarketing safety reporting requirements for combination products, which was previously issued on December 20, 2016, and is intended to help industry and FDA staff comply with the regulations.